HBAN
47
7
OKE
61
2
ZION
49
9
STX
34
2
DTE
49
16
HSY
32
3
DHI
36
3
SLB
41
2
FE
34
4
APH
53
3
DOW
47
4
IBM
53
2
GRMN
53
3
NKE
36
2
AIG
38
5
JPM
59
6
WMB
58
3
SJM
17
5
CINF
24
-8
URBN
67
3
HBAN
47
7
OKE
61
2
ZION
49
9
STX
34
2
DTE
49
16
HSY
32
3
DHI
36
3
SLB
41
2
FE
34
4
APH
53
3
DOW
47
4
IBM
53
2
GRMN
53
3
NKE
36
2
AIG
38
5
JPM
59
6
WMB
58
3
SJM
17
5
CINF
24
-8
URBN
67
3
Financhill
Back

LeMaitre Vascular Quote, Financials, Valuation and Earnings

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
58

LMAT
LeMaitre Vascular

Last Price:
$92.19
Seasonality Move:
2.06%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

LeMaitre Vascular Price Quote

$92.19
+0.06 (+-0.07%)
(Updated: December 21, 2024 at 5:35 AM ET)

LeMaitre Vascular Key Stats

Buy
58
LeMaitre Vascular (LMAT) is a Buy
Day range:
$90.61 - $93.60
52-week range:
$52.88 - $109.58
Dividend yield:
0.7%
P/E ratio:
68.75
P/S ratio:
9.79
P/B ratio:
6.26%
Volume:
435.2K
Avg. volume:
180.3K
1-year change:
67.97%
Market cap:
$2.1B
Revenue:
$193.5M
EPS:
$1.83

How Much Does LeMaitre Vascular Make?

Data Unavailable

Is LeMaitre Vascular Growing As A Company?

Data Unavailable

LeMaitre Vascular Stock Price Performance

  • Did LeMaitre Vascular Stock Go Up Last Month?
    LeMaitre Vascular share price went down by -10.93% last month
  • Did LMAT's Share Price Rise Over The Last Year?
    LMAT share price rose by 67.97% over the past 1 year

What Is LeMaitre Vascular 52-Week High & Low?

LeMaitre Vascular Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LeMaitre Vascular?

Data Unavailable

Is LeMaitre Vascular Cash Flow Positive?

Data Unavailable

LeMaitre Vascular Return On Invested Capital

Data Unavailable

LeMaitre Vascular Earnings Date & Stock Price

LeMaitre Vascular Competitors

  • Who Are LeMaitre Vascular's Competitors?
    Below is a list of companies who compete with LeMaitre Vascular or are related in some way:
    • Baxter International Inc (BAX)
    • Perspective Therapeutics Inc (CATX)
    • Globus Medical Inc (GMED)
    • Insulet Corp (PODD)
    • ResMed Inc (RMD)

LeMaitre Vascular Dividend Yield

Data Unavailable

LeMaitre Vascular Analyst Estimates

YoY Growth Past Surprise
EPS: 48.49% 13.3%
Revenue: 15.63% 2.45%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 98.78
Upside from Last Price: 7.22%

Major Shareholders

Data Unavailable